TEL AVIV, Oct 18 (Reuters) - Israeli generic drugmaker Teva Pharmaceutical Industries (TEVA.O: Quote, Profile, Research) (TEVA.TA: Quote, Profile, Research) said it would issue a statement later on Wednesday after trading in its shares in Tel Aviv was halted, following an Isreali media report that its chief executive had resigned.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.